Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke
Clinical Trials Friday, February 22nd, 2013NEJM: February 7, 2013
BACKGROUND
Endovascular therapy is increasingly used after the administration of intravenous tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic stroke, but whether a combined approach is more effective than intravenous t-PA alone is uncertain. Read more
